Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.
IPO Year: 2016
Exchange: NYSE
Website: globalmedicalreit.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/3/2025 | $9.00 | Neutral | B. Riley Securities |
| 10/18/2024 | $11.75 | Buy | Berenberg |
| 9/19/2024 | $12.00 | Buy | Alliance Global Partners |
| 10/10/2022 | $9.00 | Outperform → Neutral | Robert W. Baird |
| 10/6/2022 | $13.00 → $9.00 | Outperform → Market Perform | BMO Capital Markets |
| 7/7/2022 | Mkt Perform | JMP Securities | |
| 1/13/2022 | Overweight → Sector Weight | Keybanc | |
| 9/20/2021 | $17.00 | Overweight | Keybanc |
| 7/9/2021 | $18.00 | Buy | Colliers Securities |
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
3 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
10-Q - Global Medical REIT Inc. (0001533615) (Filer)
8-K - Global Medical REIT Inc. (0001533615) (Filer)
8-K - Global Medical REIT Inc. (0001533615) (Filer)
8-K - Global Medical REIT Inc. (0001533615) (Filer)
SCHEDULE 13G - Global Medical REIT Inc. (0001533615) (Subject)
8-K - Global Medical REIT Inc. (0001533615) (Filer)
10-Q - Global Medical REIT Inc. (0001533615) (Filer)
8-K - Global Medical REIT Inc. (0001533615) (Filer)
DEFA14A - Global Medical REIT Inc. (0001533615) (Filer)
DEF 14A - Global Medical REIT Inc. (0001533615) (Filer)
Fastest customizable press release news feed in the world
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), today announced that its Board of Directors (the "Board") approved a $50 million common stock repurchase program and reverse stock split of the Company's common stock at a ratio of one-for-five. Common Stock Repurchase Program On August 12, 2025, the Board approved a $50 million common stock repurchase program (the "Program"). Under the Program, the Company may purchase up to $50 million of its outstanding shares of common stock, par value $0.001 per share ("Common Stock"), from time to time in the open market, including through block purchases, through privately negotiated transactions or pursuant to any Rule 10b5-1 tradin
– Appoints Mark Decker, Jr. as Chief Executive Officer – – Completes Acquisition of Previously Announced $69.6 Million Five-Property Medical Portfolio – – Reaffirms Full Year 2025 AFFO Guidance – Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), today announced financial results for the three and six months ended June 30, 2025 and other data. Mark Decker, Jr., Chief Executive Officer and President stated, "I'm excited to be on board as we report our first quarter as a new team here at Global Medical. We have an outstanding niche and I look forward to honing that further and driving results for all our stakeholders in the coming years. For a fulsome discussion of the bu
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), announced today that it intends to release its second quarter 2025 financial results after the market closes on Tuesday, August 5, 2025. The Company intends to hold a conference call to discuss those results the following day, Wednesday, August 6, 2025, at 9:00 a.m. Eastern Time. The conference call will be hosted by President and Chief Executive Officer Mark Decker, Jr., Chief Financial Officer Robert Kiernan, and Chief Investment Officer Alfonzo Leon. Webcast Information Participants may access the call via live webcast by visiting the investor information section of the Company's website at https://investors.globalmedica
Ortelius Nominees Believe Brookdale Offers a Tremendous Value Creation Opportunity Under a Renewed Board and New Strategic Roadmap Six Highly Qualified and Independent Nominees Will Act with Urgency, Integrity, and Transparency to Increase Value for Stockholders Brookdale Stockholders are Urged to Vote the WHITE Proxy Card FOR all Six Ortelius Nominees Ortelius Advisors, L.P. ("Ortelius") today announced that the six highly qualified individuals nominated by Ortelius for election to the Board of Directors (the "Board") of Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company") at the upcoming 2025 Annual Meeting of Stockholders released a joint letter to Brookdale stock
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), today announced that Mark Decker, Jr. has been appointed as the Company's Chief Executive Officer and President, effective immediately. Mr. Decker, who will join the Board of Directors, succeeds Jeffrey Busch, who will continue to serve on the Board as non-executive Chairman. Lori Wittman, Lead Independent Director of the Company stated, "We are extremely pleased to announce Mark Decker, Jr. as our new Chief Executive Officer. As part of the Board's ongoing commitment and efforts to maximize shareholder value, we identified the need for a fresh, strategic perspective to guide our portfolio management and growth initiatives. M
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, announced today that its Board of Directors ("Board") has declared the Company's 2025 second quarter common and preferred dividends. Common Dividend The Board has declared the Company's 2025 second quarter cash dividend of $0.15 per share of common stock and unit, which is payable on July 9, 2025 to common stockholders and unitholders of record as of June 20, 2025. The Company has prepared an updated investor presentation which contains ce
– Completes Acquisition of Previously Announced $69.6 Million Five-Property Medical Portfolio – – Reaffirms Full Year 2025 AFFO Guidance – Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today announced financial results for the three months ended March 31, 2025 and other data. Jeffrey M. Busch, Chairman, Chief Executive Officer and President stated, "During the first quarter, we continued to deliver steady results supported by the high quality of our portfolio and stability of our tenant
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, announced today that it intends to release its first quarter 2025 financial results after the market closes on Wednesday, May 7, 2025. The Company intends to hold a conference call to discuss those results the following day, Thursday, May 8, 2025, at 9:00 a.m. Eastern Time. The conference call will be hosted by Chairman, President, and Chief Executive Officer Jeffrey Busch, Chief Financial Officer Robert Kiernan, and Chief Investment Officer Alf
Issues Letter to Stockholders to Outline the Case for Meaningful Change at Brookdale Following Years of Underperformance Ortelius' Nominees Bring Extensive Experience in Senior Housing, Real Estate, Operations, Capital Markets, and Turnaround Situations Believes New and Energized Board Will Drive Urgent Change and Unlock Significant Value for Stockholders Ortelius Advisors, L.P. today issued the following open letter to fellow stockholders of Brookdale Senior Living Inc. (NYSE:BKD). The full text of the letter follows: March 5, 2025 Fellow Stockholders, Ortelius Advisors, L.P. ("Ortelius" or "we") owns approximately 1.3% of the outstanding common stock of Brookdale Senior Living Inc.1
– Acquires $80.3 Million of Single Tenant Triple-Net Medical Real Estate in 2024 – – Announces Joint Venture with Heitman – – Announces First Quarter 2025 Common and Preferred Dividends – – Announces Full Year 2025 AFFO Guidance – Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today announced financial results for the three and twelve months ended December 31, 2024 and other data. Jeffrey M. Busch, Chairman, Chief Executive Officer and President stated, "During the year we maintain
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
B. Riley Securities resumed coverage of Global Medical REIT with a rating of Neutral and set a new price target of $9.00
Berenberg initiated coverage of Global Medical REIT with a rating of Buy and set a new price target of $11.75
Alliance Global Partners initiated coverage of Global Medical REIT with a rating of Buy and set a new price target of $12.00
Robert W. Baird downgraded Global Medical REIT from Outperform to Neutral and set a new price target of $9.00
BMO Capital Markets downgraded Global Medical REIT from Outperform to Market Perform and set a new price target of $9.00 from $13.00 previously
JMP Securities initiated coverage of Global Medical REIT with a rating of Mkt Perform
Keybanc downgraded Global Medical REIT from Overweight to Sector Weight
Keybanc initiated coverage of Global Medical REIT with a rating of Overweight and set a new price target of $17.00
Colliers Securities initiated coverage of Global Medical REIT with a rating of Buy and set a new price target of $18.00
BMO Capital initiated coverage of Global Medical REIT with a rating of Outperform and set a new price target of $16.00
Live finance-specific insights
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), today announced that its Board of Directors (the "Board") approved a $50 million common stock repurchase program and reverse stock split of the Company's common stock at a ratio of one-for-five. Common Stock Repurchase Program On August 12, 2025, the Board approved a $50 million common stock repurchase program (the "Program"). Under the Program, the Company may purchase up to $50 million of its outstanding shares of common stock, par value $0.001 per share ("Common Stock"), from time to time in the open market, including through block purchases, through privately negotiated transactions or pursuant to any Rule 10b5-1 tradin
– Appoints Mark Decker, Jr. as Chief Executive Officer – – Completes Acquisition of Previously Announced $69.6 Million Five-Property Medical Portfolio – – Reaffirms Full Year 2025 AFFO Guidance – Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), today announced financial results for the three and six months ended June 30, 2025 and other data. Mark Decker, Jr., Chief Executive Officer and President stated, "I'm excited to be on board as we report our first quarter as a new team here at Global Medical. We have an outstanding niche and I look forward to honing that further and driving results for all our stakeholders in the coming years. For a fulsome discussion of the bu
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), announced today that it intends to release its second quarter 2025 financial results after the market closes on Tuesday, August 5, 2025. The Company intends to hold a conference call to discuss those results the following day, Wednesday, August 6, 2025, at 9:00 a.m. Eastern Time. The conference call will be hosted by President and Chief Executive Officer Mark Decker, Jr., Chief Financial Officer Robert Kiernan, and Chief Investment Officer Alfonzo Leon. Webcast Information Participants may access the call via live webcast by visiting the investor information section of the Company's website at https://investors.globalmedica
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, announced today that its Board of Directors ("Board") has declared the Company's 2025 second quarter common and preferred dividends. Common Dividend The Board has declared the Company's 2025 second quarter cash dividend of $0.15 per share of common stock and unit, which is payable on July 9, 2025 to common stockholders and unitholders of record as of June 20, 2025. The Company has prepared an updated investor presentation which contains ce
– Completes Acquisition of Previously Announced $69.6 Million Five-Property Medical Portfolio – – Reaffirms Full Year 2025 AFFO Guidance – Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today announced financial results for the three months ended March 31, 2025 and other data. Jeffrey M. Busch, Chairman, Chief Executive Officer and President stated, "During the first quarter, we continued to deliver steady results supported by the high quality of our portfolio and stability of our tenant
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, announced today that it intends to release its first quarter 2025 financial results after the market closes on Wednesday, May 7, 2025. The Company intends to hold a conference call to discuss those results the following day, Thursday, May 8, 2025, at 9:00 a.m. Eastern Time. The conference call will be hosted by Chairman, President, and Chief Executive Officer Jeffrey Busch, Chief Financial Officer Robert Kiernan, and Chief Investment Officer Alf
Issues Letter to Stockholders to Outline the Case for Meaningful Change at Brookdale Following Years of Underperformance Ortelius' Nominees Bring Extensive Experience in Senior Housing, Real Estate, Operations, Capital Markets, and Turnaround Situations Believes New and Energized Board Will Drive Urgent Change and Unlock Significant Value for Stockholders Ortelius Advisors, L.P. today issued the following open letter to fellow stockholders of Brookdale Senior Living Inc. (NYSE:BKD). The full text of the letter follows: March 5, 2025 Fellow Stockholders, Ortelius Advisors, L.P. ("Ortelius" or "we") owns approximately 1.3% of the outstanding common stock of Brookdale Senior Living Inc.1
– Acquires $80.3 Million of Single Tenant Triple-Net Medical Real Estate in 2024 – – Announces Joint Venture with Heitman – – Announces First Quarter 2025 Common and Preferred Dividends – – Announces Full Year 2025 AFFO Guidance – Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today announced financial results for the three and twelve months ended December 31, 2024 and other data. Jeffrey M. Busch, Chairman, Chief Executive Officer and President stated, "During the year we maintain
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, announced today that it intends to release its fourth quarter and year-end 2024 financial results after the market closes on Thursday, February 27, 2025. The Company intends to hold a conference call to discuss those results the following day, Friday, February 28, 2025, at 9:00 a.m. Eastern Time. The conference call will be hosted by Chairman, President, and Chief Executive Officer Jeffrey Busch, Chief Financial Officer Robert Kiernan, and Chief
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, announced today that information regarding the federal income tax treatment of the dividends paid in 2024 on the Company's common and preferred stock has been posted to the Company's website, at the following link. https://investors.globalmedicalreit.com/stock-data/dividend-tax-information Stockholders should review their Forms 1099 as well as other 2024 tax statements that they will receive from their brokerage firms or other institutions t
Live Leadership Updates
Ortelius Nominees Believe Brookdale Offers a Tremendous Value Creation Opportunity Under a Renewed Board and New Strategic Roadmap Six Highly Qualified and Independent Nominees Will Act with Urgency, Integrity, and Transparency to Increase Value for Stockholders Brookdale Stockholders are Urged to Vote the WHITE Proxy Card FOR all Six Ortelius Nominees Ortelius Advisors, L.P. ("Ortelius") today announced that the six highly qualified individuals nominated by Ortelius for election to the Board of Directors (the "Board") of Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company") at the upcoming 2025 Annual Meeting of Stockholders released a joint letter to Brookdale stock
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), today announced that Mark Decker, Jr. has been appointed as the Company's Chief Executive Officer and President, effective immediately. Mr. Decker, who will join the Board of Directors, succeeds Jeffrey Busch, who will continue to serve on the Board as non-executive Chairman. Lori Wittman, Lead Independent Director of the Company stated, "We are extremely pleased to announce Mark Decker, Jr. as our new Chief Executive Officer. As part of the Board's ongoing commitment and efforts to maximize shareholder value, we identified the need for a fresh, strategic perspective to guide our portfolio management and growth initiatives. M
Chief Executive Officer Transition Expected in 2025 Mr. Busch to Remain on Board of Directors as Non-Executive Chairman Lori Wittman Appointed Lead Independent Director Effective January 1, 2025 Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today announced that as part of the Company's succession planning efforts, the Board of Directors (the "Board") has reached an agreement with Mr. Jeffrey Busch, Chairman of the Board of Directors and Chief Executive Officer ("CEO") of the Company,
This live feed shows all institutional transactions in real time.
SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)
SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)
SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)
SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)
SC 13G - Global Medical REIT Inc. (0001533615) (Subject)
SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)